2nd Quarter - Report
UPSTREAM CONSULTING for RARE ACCESS ACTION PROJECT
Firm
Client
Income
—
Expenses
—
No amount is shown when the filer reports less than $5,000 for the period, which the form does not ask them to state.
What was lobbied
3 issue areas, each in the filer's own words, with who lobbied on it and where.
Medicare/Medicaid MMM
Promote the importance of federal health programs to facilitate patient access to rare disease therapies.
| Lobbyist | Covered position, as disclosed |
|---|---|
| JOHN M. HADDOW | — |
| MCCLAIN C HADDOW | — |
Medical/Disease Research/Clinical Labs MED
Reimbursement coverage by Medicaid and Medicare for rare disease therapies.
| Lobbyist | Covered position, as disclosed |
|---|---|
| JOHN M. HADDOW | — |
| MCCLAIN C HADDOW | — |
Health Issues HCR
Reimbursement coverage for rare disease therapies.
| Lobbyist | Covered position, as disclosed |
|---|---|
| JOHN M. HADDOW | — |
| MCCLAIN C HADDOW | — |
Conviction disclosures
Disclosed by the filer under the Act's requirement to report certain convictions of its lobbyists.
| Lobbyist | Date | Description |
|---|---|---|
| MCCLAIN HADDOW | Sep 15, 1987 | 9/15/1987, U.S. District Court, 18 U.S.C. Section 208(a), conflict of interest (2 counts) |
Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.